Virtus Investment Advisers’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,483
Closed -$243K 476
2017
Q4
$243K Sell
1,483
-47
-3% -$8.43K 0.03% 376
2017
Q3
$314K Sell
1,530
-207
-12% -$48.1K 0.03% 360
2017
Q2
$422K Sell
1,737
-580
-25% -$136K 0.04% 346
2017
Q1
$554K Buy
+2,317
New +$540K 0.05% 315
2016
Q4
Sell
-13,623
Closed -$3.14M 545
2016
Q3
$3.14M Buy
+13,623
New +$3.33M 0.2% 168

Other funds holding AGN

Virtus Investment Advisers's AGN Position: Q1 2018 in Review

Virtus Investment Advisers sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 1,483 shares — an estimated $243K sold.

Virtus Investment Advisers first reported a position in AGN in Q3 2016 and held it in 5 quarters. The position peaked at $3.14M in Q3 2016. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Virtus Investment Advisers reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Virtus Investment Advisers sold 1,483 Allergan plc shares in Q1 2018, an estimated $243K.
  • Virtus Investment Advisers first reported a position in Allergan plc in Q3 2016 and held it in 5 quarters.
  • Virtus Investment Advisers's Allergan plc position peaked at $3.14M in Q3 2016.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Virtus Investment Advisers's 13F filing for Q1 2018, filed 15 May 2018.